Problems surface at younger age than in people who didn't have cancer as children, study finds

Some not clear on risks of problems, two surveys find

Prevention is as important as intervention, specialists say

The cholesterol-lowering drugs showed some benefits in preliminary trial

After hospital, they're twice as likely to be injured, so prevention strategies are key

Pills, supplements have potentially dangerous ingredients, lack warning labels, study finds

No benefit seen for prehypertensive people in morning use, researchers report

Studies find they might add to traditional risk factors

Low dose tPA dissolved masses 2 to 3 times faster, dramatically boosting survival

FDA says manufacturer of Trasylol now removing remaining stock of drug from U.S. market, following new data on increased death risk.

Especially for women, heavy consumption tied to arterial stiffening, enlarged hearts

And childhood obesity is a key culprit, study says

Experts note doses of the blood-pressure drugs given in the study were probably too high

Study finds higher levels of protein that increases levels of damaging blood fats in users

Study suggests dirty air may be even more dangerous than previously thought

Study finds signs of trouble show up even when statins, blood pressure meds are used

Study finds little more than half of patients were checked, only 39% met treatment goals

Risk for retinal vein blockage more than doubles when these conditions go untreated

In study with mice, drug prevented heart failure in those with Duchenne muscular dystrophy

Doctors divided on the risks posed by the artery-opening devices

Carotid bruits linked to increased odds of heart attack, death, study finds

Rehab with therapist had more benefit than those using robotic devices, study finds

Uncovering molecular underpinnings could lead to new, genetically targeted therapies

Long-term study, involving women, deals another blow to homocysteine theory

Blood chemicals in overweight participants were key predictors of organ failure, study says

Study saw significant declines in several death risks within 5 years of stopping

Cilostazol also resulted in fewer brain bleeds than aspirin, study finds